XBiotech (XBIT) Change in Account Payables (2014 - 2025)
XBiotech (XBIT) posted quarterly Change in Account Payables of $492000.0 for Q4 2025, down 24.66% year-over-year from $653000.0 in Q4 2024, and up 227.79% quarter-over-quarter from -$385000.0 in Q3 2025.
XBiotech (XBIT) Change in Account Payables (2014 - 2025) Analysis & Trends
XBiotech's Change in Account Payables history runs 12 years deep, the most recent figure standing at $492000.0 for Q4 2025.
- In Q4 2025, Change in Account Payables fell 24.66% year-over-year to $492000.0; the TTM figure through Dec 2025 stood at -$688000.0 (down 89.01% YoY), while the FY2025 annual figure was -$688000.0, down 89.01% from the prior year.
- Change in Account Payables for Q4 2025 stood at $492000.0, up from -$385000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $1.2 million in Q4 2021, with the low at -$1.4 million in Q1 2021.
- The 5-year median for Change in Account Payables is -$96000.0 (2024), against an average of -$55900.0.
- The sharpest annual moves came in 2021 and 2025: Change in Account Payables jumped 232.99% in 2021, then sank 14162.5% in 2025.
- XBiotech's Change in Account Payables stood at $1.2 million in 2021, then slipped by 5.75% to $1.1 million in 2022, then slipped by 6.1% to $1.0 million in 2023, then tumbled by 36.66% to $653000.0 in 2024, then declined by 24.66% to $492000.0 in 2025.
- Business Quant data shows XBIT's Change in Account Payables at $492000.0 in Q4 2025, -$385000.0 in Q3 2025, and $330000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | XBiotech | 69.51 Mn | 69.51 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 492,000.00 |
| Dec 31, 2025 | 492,000.00 |
| Sep 30, 2025 | -385,000.00 |
| Sep 30, 2025 | -385,000.00 |
| Jun 30, 2025 | 330,000.00 |
| Jun 30, 2025 | 330,000.00 |
| Mar 31, 2025 | -1.13 Mn |
| Mar 31, 2025 | -1.13 Mn |
| Dec 31, 2024 | 653,000.00 |
| Dec 31, 2024 | 653,000.00 |
| Sep 30, 2024 | -200,000.00 |
| Sep 30, 2024 | -200,000.00 |
| Jun 30, 2024 | -825,000.00 |
| Jun 30, 2024 | -825,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Dec 31, 2023 | 1.03 Mn |
| Dec 31, 2023 | 1.03 Mn |
| Sep 30, 2023 | -320,000.00 |
| Sep 30, 2023 | -320,000.00 |